Microbial Minutes: New Antibiotics, Vaccine Update, and Efficacy of Probiotics

Sept. 24, 2018

Attenuated Zika Virus May Fight Brain Cancer

Chen Q. et al. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate. mBio. Sept 18 2018.

Probiotic Efficacy Depends on Many Variables

Zmora N. et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics is Associated with Unique Host and Microbiome Features. Cell. September 6 2018.

Suez J. et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution is Impaired by Probiotics and Improved by Autologous FMT. Cell. September 6 2018.

Global Health Costs are Higher than the Current World Budget

Young R. et al. Developing New Health Technologies for Neglected Diseases: A Pipeline Portfolio Review and Cost Model. Gates Open Research. August 28 2018.

Protection from Influenza Vaccine Quickly Wanes

Ray G. et al. Intra-season Waning of Influenza Vaccine Effectiveness. Clinical Infectious Disease. September 10 2018

Scientists Develop New Drug Class To Fight Bacterial Infections

Smith PA et al. Optimized Arylomycins Are a New Class of Gram-Negative Antibiotics. Nature. September 12 2018

Antibiotic Combinations May Lengthen Efficacy of Current Drugs

Tekin E. Prevalence and Patterns of Higher-Order Drug Interactions in Escherichia coli. Systems Biology and Applications. September 3 2018.

Author: Julie Wolf

Julie Wolf
Dr. Julie Wolf is in science communications at Indie Bio, and was a former ASM employee. Follow Julie on Twitter for more ASM and microbiology highlights at @JulieMarieWolf.